Josh Hall

PHD Doctor of Philosophy,  The Johns Hopkins Hospital 

Location: Germany

Consulting Services

Scientific Writing IT-Web-Mobile Technology Legal Support

Areas Of Interest

Acetophenones Brain Tumors, Primary Lauryl Ether, Tetraethyleneglycol Exploitation, Labor Rete Testis Tumor Receptor, Anaphylatoxin C5a L1 Lac Lectin Estro-Feminal Chemokine CXCL10 Bone Morphogenetic Protein 1 Tracts, Respiratory Lactoferrin Tropheryma Seven Valent Pneumococcal PS Meningococcal OMPC Conjugate Vaccine Formularies, Dental as Topic Ethics Committee, Hospital Infection, Secernentea Mycobacterium abscessus subspecies abscessus Corium Dystrophia Myotonica 2 Syndrome, SAPHO Sepses, Neonatal Departments, Hospital Anesthesia-Resuscitation Primary Congenital Lymphedema Capsicum USF, Helix-Loop-Helix Activator Receptors, Corticosteroid longa, Curcuma Ubiquitin-Related Modifier Protein, Small Hunters Syndrome Schwannoma, Melanocytic Vestibular Gordonia Plant Drug-Induced Febrile Neutropenias Nuclear Division Solutions, Tissue Preservation Nebulizer Ethers, Hydroxyacetate

Professional Narrative

Dr. Josh Hall was born in DuBois, Pennsylvania and is a graduate of Villanova University. He obtained his medical degree at Thomas Jefferson University in Philadelphia. His residency was at Thomas Jefferson and its affiliated Wills Eye Hospital, and he completed his training with fellowships at the University of Connecticut incataract andcorneal surgery.

Dr. Hall has thirty years’ experience in ophthalmic surgery,withspecialinterestin cataract surgery,corneal transplantation,andlaserrefractiveprocedures.Heisa founding member of Precision LASIK Group, Chief of Ophthalmology at The Hospital ofCentral Connecticut,andco-medical director of the Connecticut eye bank.


Employment

Assistant Professor, Mayo Clinic 2004
Executive Director, Amgen 1987

Education

Bachelor of science in nursing, Baylor College 2010
Director Medicine, Harvard Medical School 1994

Referees


Publications

Hou X, Zaks T, Langer R, Dong Y. Lipid nanoparticles for mRNA delivery. Nat Rev Mater. 2021;6(12):1078-1094. doi: 10.1038/s41578-021-00358-0. Epub 2021 Aug 10. PMID: 34394960; PMCID: PMC8353930.

Riley RS, June CH, Langer R, Mitchell MJ. Delivery technologies for cancer immunotherapy. Nat Rev Drug Discov. 2019 Mar;18(3):175-196. doi: 10.1038/s41573-018-0006-z. PMID: 30622344; PMCID: PMC6410566.

Yin X, Mead BE, Safaee H, Langer R, Karp JM, Levy O. Engineering Stem Cell Organoids. Cell Stem Cell. 2016 Jan 7;18(1):25-38. doi: 10.1016/j.stem.2015.12.005. PMID: 26748754; PMCID: PMC4728053.

Yin X, Mead BE, Safaee H, Langer R, Karp JM, Levy O. Engineering Stem Cell Organoids. Cell Stem Cell. 2016 Jan 7;18(1):25-38. doi: 10.1016/j.stem.2015.12.005. PMID: 26748754; PMCID: PMC4728053.


Grants,Awards and Certifications

Grants :

No Grants Mentioned !!

Awards & Prizes :


Languages

Language Proficiency :

Translation Services :